Form 8-K - Current report:
SEC Accession No. 0001144204-09-011408
Filing Date
2009-02-27
Accepted
2009-02-27 16:59:38
Documents
5
Period of Report
2009-02-23
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v141452_8k.htm 8-K 34841
2 v141452_ex99-1.htm EX-99.1 645
3 GRAPHIC v141452_ex99-1x1x1.jpg GRAPHIC 110772
4 GRAPHIC v141452_ex99-1x2x1.jpg GRAPHIC 124444
5 GRAPHIC v141452_ex99-1x3x1.jpg GRAPHIC 41845
  Complete submission text file 0001144204-09-011408.txt   419354
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51172 | Film No.: 09643952
SIC: 2834 Pharmaceutical Preparations